BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
BD installed new needle and syringe production lines at plants in Connecticut and Nebraska. One is already fully operational and the company expects additional lines to start up in the coming months.
BD will close a facility in Caesarea, Israel, by the middle of the year. BD bought the site along with Caesarea Medical ...
As part of a $10 million investment in 2024, new production lines for needles and syringes have been installed at BD's plants in Connecticut and Nebraska, with one line already operational ...
Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging ...
As part of the company's 2024 investment of more than $10 million to expand manufacturing capacity, new needle and syringe production lines have been installed at the BD plants in Connecticut and ...
A Bronx council member wants to force the city’s Department of Health and Mental Hygiene to pick up used drug needles that ...
BD (NYSE:BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...